Product complaint #: (b)(4).Date sent to the fda: 01/28/2020.Additional information: a3, d10,h6.Additional h3 device evaluation summary: one open sample of product code sxpp1a400, lot pcz679 was returned for analysis.During the visual inspection of the opened sample, the swage and attachment area were noted to be as expected.However, marks on the body needle and the end of the suture piece cut by the use of a surgical instrument could be observed.Addition, some barbs were found damaged and body fluids were found along of the strand.The product code sxpp1a400 contains an absorbable suture and as the sample was received open, the time of exposure that has the suture in the environment could not be determined and no additional test could be performed.As with any device, care should be taken to avoid damage to the strand when handling.Avoid the crushing or crimping action of the surgical instruments, such as needle holders and forceps.Due to condition of the opened sample, the assignable cause of performance breakage suture suggests an improper handling.
|